Usage of epidermal growth factor mutation testing and impact on treatment patterns in non-small cell lung cancer: An international observational study

Janakiraman Subramanian,Natasha B Leighl,Yoon-La Choi,Teh-Ying Chou, Jeffrey Gregg,Rina Hui,Antonio Marchetti,Mark Silvey, Rebecca Makin,Liane Gillespie-Akar,Aliki Taylor,Doreen A Kahangire,Tom Bailey, Maiyan Chau,Neal Navani

Lung Cancer（2023）

引用 1|浏览23

暂无评分

摘要

•Over one-fifth of patients wait > 14 days for their EGFR mutation test results.•One-fifth of patients never receive EGFR tyrosine kinase inhibitor treatment.•Significant inter-country variability exists in patients receiving EGFR treatment.•Improvement in EGFR mutation testing turnaround times and treatment is needed.

查看译文

关键词

Epidermal growth factor receptor (EGFR),EGFR mutation,Non-small cell lung cancer,Real-world data,Biomarker testing turnaround time,Epidermal growth factor receptor tyrosine kinase inhibitor

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要